Contact
Please use this form to send email to PR contact of this press release:
Yingli Pharma Announces First Patient Dosed in Phase 2 Trial of Linperlisib for Peripheral T Cell Lymphoma
TO:
Please use this form to send email to PR contact of this press release:
Yingli Pharma Announces First Patient Dosed in Phase 2 Trial of Linperlisib for Peripheral T Cell Lymphoma
TO: